BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2891285)

  • 1. Contrast agent nephrotoxicity: comparison of ionic and nonionic contrast agents.
    Stacul F; Carraro M; Magnaldi S; Faccini L; Guarnieri G; Dalla Palma L
    AJR Am J Roentgenol; 1987 Dec; 149(6):1287-9. PubMed ID: 2891285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients.
    Scherberich JE; Fischer A; Rautschka E; Kollath J; Riemann H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():91-4. PubMed ID: 2568816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and hepatic tolerance of nonionic and ionic contrast media in intravenous digital subtraction angiography.
    Langer M; Junge W; Keysser R; Hasford J; Jänicke UA
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():95-100. PubMed ID: 2568817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings.
    Katholi RE; Taylor GJ; Woods WT; Womack KA; Katholi CR; McCann WP; Moses HW; Dove JT; Mikell FL; Woodruff RC
    Radiology; 1993 Jan; 186(1):183-7. PubMed ID: 8416561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac complications of intravenous digital angiography. Comparison of ionic and nonionic contrast media].
    Stacul F; Marass P; Pozzi Mucelli R; Predonzan F; Magnaldi S; Abbona M
    Radiol Med; 1985; 71(1-2):40-3. PubMed ID: 4023305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular contrast media: effect of dose on renal function.
    Miller DL; Chang R; Wells WT; Dowjat BA; Malinosky RM; Doppman JL
    Radiology; 1988 Jun; 167(3):607-11. PubMed ID: 3363118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent.
    Schwab SJ; Hlatky MA; Pieper KS; Davidson CJ; Morris KG; Skelton TN; Bashore TM
    N Engl J Med; 1989 Jan; 320(3):149-53. PubMed ID: 2643042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contrast media in venous digital angiography: ionic or non-ionic?].
    Stacul F; Magnaldi S; Pozzi-Mucelli R; Muner G; Dalla Palma L
    Radiol Med; 1986 Nov; 72(11):815-22. PubMed ID: 3786845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubular nephrotoxicity after intravenous urography with ionic high-osmolal and nonionic low-osmolal contrast media in patients with chronic renal insufficiency.
    Cavaliere G; Arrigo G; D'Amico G; Bernasconi P; Schiavina G; Dellafiore L; Vergnaghi D
    Nephron; 1987; 46(2):128-33. PubMed ID: 2885767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered urinary beta 2-microglobulin excretion as an index of nephrotoxicity.
    Rashad FA; Vacca CV; Speroff T; Hall PW
    Kidney Int Suppl; 1991 Nov; 34():S18-20. PubMed ID: 1762326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity from contrast media: attenuation with theophylline.
    Katholi RE; Taylor GJ; McCann WP; Woods WT; Womack KA; McCoy CD; Katholi CR; Moses HW; Mishkel GJ; Lucore CL
    Radiology; 1995 Apr; 195(1):17-22. PubMed ID: 7892462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iopamidol: new, nonionic contrast agent for excretory urography.
    Thompson WM; Foster WL; Halvorsen RA; Dunnick NR; Rommel AJ; Bates M
    AJR Am J Roentgenol; 1984 Feb; 142(2):329-32. PubMed ID: 6607602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfemoral digital subtraction aortography. Are diluted high osmolar contrast media acceptable?
    Naisby GP; Owen JP; Alexander TW; Cope L; Laker MF; Hamilton PJ
    Acta Radiol; 1991 Mar; 32(2):137-40. PubMed ID: 2031798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal toxicity of contrast agents: iopamidol, iothalamate, and diatrizoate.
    Gale ME; Robbins AH; Hamburger RJ; Widrich WC
    AJR Am J Roentgenol; 1984 Feb; 142(2):333-5. PubMed ID: 6607603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary protein excretion following intravenously administered ionic and non-ionic contrast media in man.
    Skovgaard N; Holm J; Hemmingsen L; Skaarup P
    Acta Radiol; 1989; 30(5):517-9. PubMed ID: 2692667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of an ionic and a nonionic (sodium meglumine diatrizoate and iopromide) x-ray contrast medium of hemorrheology.
    Strecker EP; Stengel M; Witte S
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():24-7. PubMed ID: 2568803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography.
    Gertz EW; Wisneski JA; Chiu D; Akin JR; Hu C
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):250-8. PubMed ID: 3881496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of fibrillation with isotonic contrast media for intra-arterial coronary digital subtraction angiography.
    Morris TW; Hayakawa K; Sahler LG; Ekholm S
    Diagn Imaging Clin Med; 1986; 55(3):109-13. PubMed ID: 3522039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital subtraction angiography. Comparison of meglumine-Na diatrizoate with iohexol.
    Sackett JF; Bergsjordet B; Seeger JF; Cacayorin ED
    Invest Radiol; 1985; 20(1 Suppl):S58-61. PubMed ID: 2579044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal excretion of iopromide and iopamidol after intravenous administration in digital subtraction angiography.
    Mützel W; Langer M; Keysser R
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():101-4. PubMed ID: 2568774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.